Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma

We aimed to explore the effects of (90)Y-DOTATOC and (90)Y-DOTATOC plus (177)Lu-DOTATOC on survival of patients with metastasized gastrinoma. Patients with progressive metastasized gastrinoma were treated with repeated cycles of (90)Y-DOTATOC or with cycles alternating between (90)Y-DOTATOC and (177...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Nucl Med Mol Imaging
Auteurs principaux: Dumont, Rebecca A, Seiler, Daniela, Marincek, Nicolas, Brunner, Philippe, Radojewski, Piotr, Rochlitz, Christoph, Müller-Brand, Jan, Maecke, Helmut R, Briel, Matthias, Walter, Martin A
Format: Artigo
Langue:Inglês
Publié: e-Century Publishing Corporation 2014
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4299770/
https://ncbi.nlm.nih.gov/pubmed/25625026
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires